ADAG Stock Analysis: Buy, Sell, or Hold?
ADAG - Adagene Inc. American Depositary Shares
$3.39
-0.11 (-3.14%)
▼
5d:
-10.55%
30d:
-14.61%
90d:
+3.04%
HOLD
MODERATE Confidence
Analysis Updated: May 18, 2026 12:00 AM ET
Earnings: Apr 01, 2026
0d
Get Alerted When ADAG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ADAG shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ADAG shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ADAG is currently trading at $3.39, which is considered oversold relative to its 30-day fair value range of $3.58 to $3.84.
Technical Outlook: Technically, ADAG is in a strong uptrend. Immediate support is located at $3.21, while resistance sits at $3.81. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: ADAG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $9.40 (+177.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ADAG is in a strong uptrend. Immediate support is located at $3.21, while resistance sits at $3.81. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: ADAG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $9.40 (+177.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.58 -
$3.84
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading 177.3% below Wall St target ($9.40)
- CAUTION: 5-day price weakness (-10.6%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$3.58 -
$3.84
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.21
Resistance Level
$3.81
Current Trend
Strong Uptrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.52
Wall Street Target
$9.40
(+177.3%)
Revenue Growth (YoY)
7332.8%
Profit Margin
-229.6%
Share & Embed Analysis
Last updated: May 18, 2026 8:21 PM ET
Data refreshes hourly during market hours. Next update: 9:21 PM
Data refreshes hourly during market hours. Next update: 9:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADAG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 52 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 61 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 57 HOLD |
